Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Free Cash Flow (2019 - 2026)

Alx Oncology Holdings' Free Cash Flow history spans 5 years, with the latest figure at -$39.8 million for Q4 2023.

  • On a quarterly basis, Free Cash Flow fell 89.13% to -$39.8 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$131.6 million, a 45.22% decrease, with the full-year FY2025 number at -$84.4 million, up 31.06% from a year prior.
  • Free Cash Flow hit -$39.8 million in Q4 2023 for Alx Oncology Holdings, down from -$29.9 million in the prior quarter.
  • Over the last five years, Free Cash Flow for ALXO hit a ceiling of -$2.8 million in Q4 2019 and a floor of -$39.8 million in Q4 2023.
  • Historically, Free Cash Flow has averaged -$18.6 million across 5 years, with a median of -$19.2 million in 2021.
  • Biggest five-year swings in Free Cash Flow: tumbled 384.57% in 2020 and later soared 42.69% in 2021.
  • Tracing ALXO's Free Cash Flow over 5 years: stood at -$2.8 million in 2019, then crashed by 384.57% to -$13.6 million in 2020, then crashed by 30.26% to -$17.7 million in 2021, then fell by 18.64% to -$21.1 million in 2022, then crashed by 89.13% to -$39.8 million in 2023.
  • Business Quant data shows Free Cash Flow for ALXO at -$39.8 million in Q4 2023, -$29.9 million in Q3 2023, and -$33.4 million in Q2 2023.